[HTML][HTML] The Administration of Levodopa in a Patient With Parkinson's Disease Using a Novel Maxillofacial Route: A First-in-Human Report
S Thirunavukarasu, BBV Ramanan, SK Suresh… - Cureus, 2023 - ncbi.nlm.nih.gov
Parkinson's disease is characterized by the loss of nigrostriatal dopaminergic neurons in the
brain. Dopamine cannot be administered systemically because it does not cross the blood …
brain. Dopamine cannot be administered systemically because it does not cross the blood …